Latest Financial Position News

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Recharge Metals has completed the acquisition of the Sunset Well Gold Project near Leonora, WA, backed by a $6 million capital raise. The project hosts a 94,500-ounce inferred gold resource with significant exploration upside.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

dorsaVi has launched a multi-year partnership with Taiwan’s ITRI and NTU to develop its proprietary RRAM platform at the 22-nm node, complemented by a new advisory board and neuromorphic IP acquisition, positioning the company at the forefront of ultra-edge AI hardware.

Osmond Resources is progressing its Orión EU Critical Minerals Project with promising drilling results, positive mineral processing testwork, and a new partnership targeting rare earth carbonate production in Spain.

Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.

Venus Metals Corporation advances its Sandstone gold and Youanmi base metals projects with new exploration targets, hyperspectral imaging breakthroughs, and ongoing development work, supported by a solid cash and investment position.

Osteopore Limited posted a 10% quarter-on-quarter revenue increase to AUD 754K in Q1 CY26, driven by new distribution deals across China, Latin America, and Hong Kong, alongside launching 3D printing services and securing innovative bone graft technologies in Asia Pacific.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Livium Ltd boosted battery recycling revenue and secured a new centralised hub to expand capacity, while advancing rare earth and solar panel recycling technologies. Strategic funding for its lithium cathode plant remains under review.

Medallion Metals has greenlit development at Ravensthorpe following a $50 million loan and environmental approval, while integrating Forrestania assets to underpin a multi-source gold strategy.

Appen Limited’s Q1 FY26 revenue rose 9% year-on-year to $54.8 million, driven by an 88% surge in its China business. Despite a 37% drop in the Global segment due to seasonality, the company reaffirmed full-year guidance and highlighted expanding AI operational efficiencies.